{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:33:30Z","timestamp":1761676410420},"reference-count":82,"publisher":"Elsevier","isbn-type":[{"value":"9780444632654","type":"print"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/b978-0-444-63265-4.00009-1","type":"book-chapter","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T15:22:17Z","timestamp":1469805737000},"page":"199-213","source":"Crossref","is-referenced-by-count":1,"title":["Enrichment and Separation Technologies for Stem Cell-Based Therapies"],"prefix":"10.1016","author":[{"given":"G.M.C.","family":"Rodrigues","sequence":"first","affiliation":[]},{"given":"T.G.","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"C.A.V.","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"M.M.","family":"Diogo","sequence":"additional","affiliation":[]},{"given":"J.M.S.","family":"Cabral","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib1","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.stem.2012.05.010","article-title":"The promise and perils of stem cell therapeutics","volume":"10","author":"Daley","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib2","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0167-7799(98)01196-2","article-title":"The development of bioengineered skin","volume":"16","author":"Kirsner","year":"1998","journal-title":"Trends Biotechnol."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09915","article-title":"Modeling schizophrenia using human induced pluripotent stem cells","volume":"473","author":"Brennand","year":"2011","journal-title":"Nature"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.stem.2013.01.009","article-title":"Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular AB and differential drug responsiveness","volume":"12","author":"Kondo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004052","article-title":"Drug screening for ALS using patient-specific induced pluripotent stem cells","volume":"4","author":"Egawa","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib7","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1056\/NEJMcibr1200138","article-title":"Stem cells and spinal cord repair","volume":"366","author":"Snyder","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib8","series-title":"Tokyo: UMIN Center, the University of Tokyo Hospital (Japan); a Study of Transplantation of Autologous Induced Pluripotent Stem Cell (IPSC) Derived Retinal Pigment Epithelium RPE Cell Sheet in Subject with Exudative AMD","author":"UMIN Clinical Trials Registry","year":"2013"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11427-014-4791-2","article-title":"Cell therapy for macular degeneration\u2013first phase I\/II pluripotent stem cell-based clinical trial shows promise","volume":"58","author":"Chen","year":"2015","journal-title":"Sci. China. Life Sci."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrc3034","article-title":"The tumorigenicity of human embryonic and induced pluripotent stem cells","volume":"11","author":"Ben-David","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib11","doi-asserted-by":"crossref","first-page":"e1000029","DOI":"10.1371\/journal.pmed.1000029","article-title":"Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient","volume":"6","author":"Amariglio","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib12","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm.3267","article-title":"Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies","volume":"19","author":"Lee","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","article-title":"Stem cell therapies in clinical trials: progress and challenges","volume":"17","author":"Trounson","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5966\/sctm.2014-0110","article-title":"Workshop review\u202f: understanding and assessing the risks of stem cell-based therapies","volume":"4","author":"Heslop","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2141.2004.05062.x","article-title":"CD34 cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients","volume":"126","author":"Ringhoffer","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/14653240903348301","article-title":"Positive immunomagnetic CD34(+) cell selection in haplo-identical transplants in beta-thalassemia patients: removal of platelets using an automated system","volume":"12","author":"Zinno","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3171\/2013.3.PEDS12397","article-title":"Central nervous system stem cell transplantation for\u00a0children with neuronal ceroid lipofuscinosis","volume":"11","author":"Selden","year":"2013","journal-title":"J.\u00a0Neurosurg. Pediatr."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib18","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/stem.207","article-title":"Intramuscular transplantation of G-CSF-Mobilized CD341 cells in patients with critical limb ischemia: a phase I\/IIa, multicenter, single-blinded, dose-escalation clinical trial","volume":"27","author":"Kawamoto","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2141.2008.07492.x","article-title":"Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials","volume":"144","author":"Brooke","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib20","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/resp.12343","article-title":"A\u00a0phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis","volume":"19","author":"Chambers","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/bmb\/ldt034","article-title":"Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies","volume":"108","author":"Ratcliffe","year":"2013","journal-title":"Br. Med. Bull."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib22","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(12)60028-2","article-title":"Embryonic stem cell trials for macular degeneration: a preliminary report","volume":"379","author":"Schwartz","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib24","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science (80-. )"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib25","first-page":"6736","article-title":"Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1\/2 studies","author":"Schwartz","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib26","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1002\/stem.149","article-title":"Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration","volume":"27","author":"Lu","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/511019a","article-title":"Hope on the line","volume":"511","author":"Hayden","year":"2014","journal-title":"Nature"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib28","doi-asserted-by":"crossref","first-page":"e37004","DOI":"10.1371\/journal.pone.0037004","article-title":"A\u00a0scalable system for production of functional pancreatic progenitors from human embryonic stem cells","volume":"7","author":"Schulz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nbt.1931","article-title":"Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells","volume":"29","author":"Kelly","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib30","first-page":"1","article-title":"Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report","author":"Menasch\u00e9","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.tibtech.2012.03.003","article-title":"Process engineering of human pluripotent stem cells for clinical application","volume":"30","author":"Serra","year":"2012","journal-title":"Trends Biotechnol."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib32","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1634\/stemcells.2007-0576","article-title":"Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1","volume":"26","author":"Choo","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib33","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/stem.109","article-title":"mAb 84, a cytotoxic antibody that kills undifferentiated human embryonic stem cells via oncosis","volume":"27","author":"Tan","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib34","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1038\/ncomms2992","article-title":"Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells","volume":"4","author":"Ben-David","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib35","doi-asserted-by":"crossref","first-page":"E3281","DOI":"10.1073\/pnas.1303669110","article-title":"Inhibition of pluripotent stem cell-derived teratoma formation by small molecules","volume":"110","author":"Lee","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib36","first-page":"1","article-title":"Controlling the survival of human pluripotent stem cells by small molecule-based targeting of topoisomerase II alpha","author":"Ben-David","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib37","doi-asserted-by":"crossref","first-page":"e85039","DOI":"10.1371\/journal.pone.0085039","article-title":"A\u00a0new class of pluripotent stem cell cytotoxic small molecules","volume":"9","author":"Richards","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib38","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1021\/ja501795c","article-title":"Selective elimination of human pluripotent stem cells by a marine natural product derivative","volume":"136","author":"Kuo","year":"2014","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.5966\/sctm.2014-0163","article-title":"Inhibition of an NAD+ salvage pathway provides efficient and selective toxicity to human pluripotent stem cells","volume":"4","author":"Kropp","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib40","first-page":"253","article-title":"Selective depletion of SSEA-3-and TRA-1-60-positive undifferentiated human embryonic stem cells by magnetic activated cell sorter (MACS)","volume":"8","author":"Kim","year":"2011","journal-title":"Tissue Eng. Regen. Med."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib41","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1089\/ten.tea.2011.0311","article-title":"Selective removal of undifferentiated human embryonic stem cells using magnetic activated cell sorting followed by a cytotoxic antibody","volume":"18","author":"Schriebl","year":"2012","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib42","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12015-013-9482-z","article-title":"Integrated platform for production and purification of human pluripotent stem cell-derived neural precursors","volume":"10","author":"Rodrigues","year":"2013","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib43","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/mt.2011.51","article-title":"Safeguarding nonhuman primate iPS cells with suicide genes","volume":"19","author":"Zhong","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/mt.2015.100","article-title":"An inducible caspase-9 suicide gene to improve the safety of therapy using human induced pluripotent stem cells","author":"Yagyu","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib45","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1016\/j.biomaterials.2012.01.023","article-title":"Protecting against wayward human induced pluripotent stem cells with a suicide gene","volume":"33","author":"Cheng","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib46","doi-asserted-by":"crossref","first-page":"e70543","DOI":"10.1371\/journal.pone.0070543","article-title":"Lentiviral vector mediated thymidine kinase expression in pluripotent stem cells enables removal of tumorigenic cells","volume":"8","author":"Lim","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","article-title":"Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes","volume":"12","author":"Tohyama","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib48","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nmeth.2999","article-title":"Chemically defined generation of human cardiomyocytes","volume":"11","author":"Burridge","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5966\/sctm.2014-0072","article-title":"A\u00a0massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes","volume":"3","author":"Hemmi","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib50","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1089\/scd.2013.0125","article-title":"Epigenetic regulation of the electrophysiological phenotype of human embryonic stem cell-derived ventricular cardiomyocytes: insights for driven maturation and hypertrophic growth","volume":"22","author":"Chow","year":"2013","journal-title":"Stem Cells Dev."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib51","doi-asserted-by":"crossref","first-page":"e65963","DOI":"10.1371\/journal.pone.0065963","article-title":"Induced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissues","volume":"8","author":"Christoforou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib52","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","article-title":"ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering","volume":"31","author":"Gaj","year":"2013","journal-title":"Trends Biotechnol."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bit.25096","article-title":"Expanding the scope of site-specific recombinases for genetic and metabolic engineering","volume":"111","author":"Gaj","year":"2014","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib54","series-title":"Efficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches Resource Efficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches","first-page":"1","author":"Miki","year":"2015"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.chroma.2006.05.089","article-title":"Affinity cryogel monoliths for screening for optimal separation conditions and chromatographic separation of cells","volume":"1123","author":"Dainiak","year":"2006","journal-title":"J.\u00a0Chromatogr. A"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib56","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jim.2003.09.017","article-title":"Affinity fractionation of lymphocytes using a monolithic cryogel","volume":"283","author":"Kumar","year":"2003","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib57","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1038\/nprot.2010.135","article-title":"Cell separation using cryogel-based affinity chromatography","volume":"5","author":"Kumar","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib58","doi-asserted-by":"crossref","first-page":"e53933","DOI":"10.1371\/journal.pone.0053933","article-title":"Evaluation of a novel non-destructive catch and release technology for harvesting autologous adult stem cells","volume":"8","author":"Bryan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib59","first-page":"151","article-title":"Cell partitioning in aqueous two-phase polymer systems","volume":"106","author":"Cabral","year":"2007","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib60","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/bit.10080","article-title":"Type-specific separation of animal cells in aqueous two-phase systems using antibody conjugates with temperature-sensitive polymers","volume":"75","author":"Kumar","year":"2001","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib61","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s10529-011-0727-0","article-title":"A\u00a0novel method for human hematopoietic stem\/progenitor cell isolation from umbilical cord blood based on immunoaffinity aqueous two-phase partitioning","volume":"33","author":"Sousa","year":"2011","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib62","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jmr.2374","article-title":"Application of affinity aqueous two-phase systems for the fractionation of CD133(+) stem cells from human umbilical cord blood","volume":"28","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2015","journal-title":"J.\u00a0Mol. Recognit."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib63","doi-asserted-by":"crossref","first-page":"e23657","DOI":"10.1371\/journal.pone.0023657","article-title":"Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression","volume":"6","author":"Uosaki","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib64","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.scr.2012.10.005","article-title":"Efficient neuronal in\u00a0vitro and in\u00a0vivo differentiation after immunomagnetic purification of mESC derived neuronal precursors","volume":"10","author":"Barral","year":"2013","journal-title":"Stem Cell Res."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib65","doi-asserted-by":"crossref","first-page":"e39715","DOI":"10.1371\/journal.pone.0039715","article-title":"Highly pure and expandable PSA-NCAM-positive neural precursors from human ESC and iPSC-derived neural rosettes","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib66","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.scr.2014.06.008","article-title":"CD133-enriched xeno-free human embryonic-derived neural stem cells expand rapidly in culture and do not form teratomas in immunodeficient mice","volume":"13","author":"Haus","year":"2014","journal-title":"Stem Cell Res."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib67","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cite.201200175","article-title":"Integrated clinical scale manufacturing system for cellular products derived by magnetic cell separation, centrifugation and cell culture","volume":"85","author":"Apel","year":"2013","journal-title":"Chem. Ing. Tech."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib68","doi-asserted-by":"crossref","DOI":"10.3727\/096368914X684899","article-title":"Transplantation of purified autologous leukapheresis-derived CD34+ and CD133+ stem cells for patients with chronic spinal cord injuries: long-term evaluation of safety and efficacy","author":"Al-Zoubi","year":"2014","journal-title":"Cell Transplant."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib69","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/biot.200900115","article-title":"Stem cell separation: a bottleneck in stem cell therapy","volume":"5","author":"Schriebl","year":"2010","journal-title":"Biotechnol. J."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib70","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1063\/1.1685647","article-title":"Fluorescence activated cell sorting","volume":"43","author":"Bonner","year":"1972","journal-title":"Rev. Sci. Instrum."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib71","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nbt1050","article-title":"Microfluidic sorting of mammalian cells by optical force switching","volume":"23","author":"Wang","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib72","doi-asserted-by":"crossref","first-page":"043001","DOI":"10.1063\/1.3511706","article-title":"Recent advancements in optofluidic flow cytometer","volume":"4","author":"Cho","year":"2010","journal-title":"Biomicrofluidics"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib73","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1634\/stemcells.2005-0137","article-title":"Fluorescence-activated cell sorting-based purification of embryonic stem cell-derived neural precursors averts tumor formation after transplantation","volume":"24","author":"Fukuda","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib74","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.stemcr.2013.10.007","article-title":"Derivation and FACS-mediated purification of PAX3+\/PAX7+ skeletal muscle precursors from human pluripotent stem cells","volume":"1","author":"Borchin","year":"2013","journal-title":"Stem Cell Rep."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib75","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.stemcr.2013.08.007","article-title":"Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a nonhuman primate","volume":"1","author":"Morizane","year":"2013","journal-title":"Stem Cell Rep."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib76","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/nprot.2015.075","article-title":"Generation and isolation of oligodendrocyte progenitor cells from human pluripotent stem cells","volume":"10","author":"Douvaras","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib77","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.stemcr.2014.06.012","article-title":"Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells","volume":"3","author":"Douvaras","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib78","doi-asserted-by":"crossref","first-page":"476","DOI":"10.5966\/sctm.2014-0166","article-title":"Development of a universal RNA beacon for exogenous gene detection","volume":"4","author":"Guo","year":"2015","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib79","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1038\/nprot.2014.154","article-title":"Molecular beacon-enabled purification of living cells by targeting cell type-specific mRNAs","volume":"9","author":"Wile","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib80","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.biomaterials.2015.01.043","article-title":"Molecular beacon-based detection and isolation of working-type cardiomyocytes derived from human pluripotent stem cells","volume":"50","author":"Jha","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib81","first-page":"44","article-title":"Fluorescence-activated cell sorting for CGMP processing of therapeutic cells","volume":"8","author":"Mcintyre","year":"2010","journal-title":"BioProcess Tech."},{"key":"10.1016\/B978-0-444-63265-4.00009-1_bib82","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4110\/in.2013.13.2.43","article-title":"Multiparameter flow cytometry: advances in high resolution analysis","volume":"13","author":"Donnell","year":"2013","journal-title":"Immune Netw."}],"container-title":["Stem Cell Manufacturing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780444632654000091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780444632654000091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T01:35:23Z","timestamp":1533173723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780444632654000091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9780444632654"],"references-count":82,"URL":"https:\/\/doi.org\/10.1016\/b978-0-444-63265-4.00009-1","relation":{},"subject":[],"published":{"date-parts":[[2016]]}}}